We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Pioneering Method Rapidly Identifies Specific Pathogenic Strains

By LabMedica International staff writers
Posted on 25 Jul 2013
Print article
Image: Scanning electron micrograph of Escherichia coli (Photo courtesy of Janice Haney Carr/CDC).
Image: Scanning electron micrograph of Escherichia coli (Photo courtesy of Janice Haney Carr/CDC).
A statistical framework called Pathoscope has been created to identify pathogenic genetic sequences from infected tissue samples.

This unique approach can accurately discriminate between closely related strains of the same species with little coverage of the pathogenic genome. The method also can determine the complete composition of known pathogenic and benign organisms in a biological sample.

Collaborating scientists from Boston University School of Medicine (MA, USA) and George Washington University (GWU; Washington DC, USA) have described an accurate and efficient approach to analyze next-generation sequence data for species identification and strain attribution that capitalizes on a Bayesian statistical framework, implemented in the new software package Pathoscope v1.0. The approach accommodates information on sequence quality, mapping quality, and provides posterior probabilities of matches to a known database of reference genomes.

The Pathoscope method will be relevant in a broad range of scenarios. In hospitals, this sequencing method will allow for rapid screening of thousands of infectious pathogens simultaneously, while being sensitive enough to monitor disease outbreaks caused by specific pathogenic strains. The approach was demonstrated by application to next-generation DNA sequence data from a recent outbreak of Escherichia coli (O104:H4) in Europe. The outbreak resulted in a number of deaths that may have been prevented by an early identification of the affecting pathogen. No other method can accurately identify multiple species or substrains in such a direct and automatic way. Current methods, such as the standard polymerase chain reaction detection or microscope observation, are often imperfect and time-consuming.

Evan Johnson, PhD, the principal investigator, said, “Pathoscope is like completing a complex jigsaw puzzle. Instead of manually assembling the puzzle, which can take days or weeks of tedious effort, we use a statistical algorithm that can determine how the picture should look without actually putting it together. Our method can characterize a biological sample faster, more accurately and in a more automated fashion than any other approach out there.” The study was published on July 10, 2013, in the journal Genome Research.

Related Links:
Boston University School of Medicine
George Washington University


New
Gold Member
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
New
Gold Member
Chagas Disease Test
CHAGAS Cassette
New
FAP Immunoassay
Quantikine QuicKit Human FAP ELISA
New
Toxoplasma Rapid Test
Toxo IgG/IgM Rapid Test Kit

Print article

Channels

Immunology

view channel
Image: The discovery of biomarkers could improve endometrial cancer treatment (Photo courtesy of Mount Sinai)

Simple Blood Test Could Help Choose Better Treatments for Patients with Recurrent Endometrial Cancer

Endometrial cancer, which develops in the lining of the uterus, is the most prevalent gynecologic cancer in the United States, affecting over 66,000 women annually. Projections indicate that in 2025, around... Read more

Pathology

view channel
Image: As tumor cells flow through these microfluidic chambers, they are subjected to increasing shear stress and sorted based on their adhesion strength (Photo courtesy of UC San Diego)

Microfluidic Device Assesses Stickiness of Tumor Cells to Predict Cancer Spread

Ductal carcinoma in situ (DCIS), a type of early-stage breast cancer, is often referred to as stage zero breast cancer. In many cases, it remains harmless and does not spread beyond the milk ducts where... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.